Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe
Provides Important Foundation as Company Advances European Commercial Plans for ARIKACE to Treat Lung Infections in Cystic Fibrosis Patients
Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing an inhaled anti-infective to treat patients battling serious lung diseases in orphan indications that are often life-threatening, today announced that the European Patent Office intends to grant E.U. Patent No. 1909759 for ARIKACE® (liposomal amikacin for inhalation). Once granted, the composition of matter patent provides exclusivity in any of the European Patent Office's member states where Insmed chooses to file at least through July 19, 2026. The Company's liposomal amikacin for inhalation is in clinical development to treat cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections and patients with nontuberculous mycobacteria (NTM) lung infections.
Asanko's Pre-Feasibility Study Confirms Robust Project Economics for Esaase Gold Project
Asanko Gold Inc. ('Asanko' or the 'Company') (TSX:AKG)(NYSE MKT:AKG) is pleased to announce that the Pre-Feasibility Study ('PFS') for its flagship Esaase Gold Project in Ghana, West Africa ('Esaase' or the 'Project'), has confirmed the technical and economic viability of the Project. All currency in this news release is quoted in United States Dollars unless otherwise stated.
Highlights of the PFS (based on $1,400 per ounce gold price) are, as follows:Proven & Probable Mineral Reserves of 2.37 million ounces of gold at 1.41 g/t. Robust project economics with an after-tax IRR of 23.2% and an NPV (5%) of $354.7 million.
Synacor Selected for Google I/O 2013 Developer Sandbox
Synacor to Showcase Cloud ID Social Login with Google+ Sign-In for TV Everywhere Sites and Apps, Google I/O, May 15-17, Moscone West Convention Center, San Francisco, Calif.
Synacor Inc. (SYNC), the leading provider of next-gen startpages, award-winning TV Everywhere solutions, and cloud-based Identity Management (IDM) services, across multiple devices for cable, satellite, telecom and consumer electronics companies, will demo Cloud ID Social Login with Google+ and advanced TV Everywhere technologies in the Developer Sandbox at Google I/O, May 15-17, Moscone West Convention Center in San Francisco, Calif. Developers and technologists will discuss with Synacor how Social Login, recently named as a TMC Cable Spotlight Product of the Year, was built to break down TV Everywhere barriers, and how they can integrate similar technologies for their customers.
Nanosphere Announces Distribution and Collaboration Agreement With Hitachi High-Technologies Corporation
Nanosphere, Inc. (NASDAQ: NSPH)Hitachi High-Technologies Corporation Provides Distribution Network to Market the Verigene System in Japan's High Growth Molecular Diagnostic Market Collaboration Leverages Each Companies' Advanced Design, Development and Manufacturing Expertise for Future Assays and Platforms
Nanosphere, Inc. (NASDAQ: NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, announced today it has signed a distribution and collaboration agreement with Hitachi High-Technologies Corporation (Hitachi High-Tech). The agreement grants Hitachi High-Tech exclusive rights to market Nanosphere products in Japan. As well, the two companies intend to collaborate on assay and platform development.
Soltoro's Equity/Royalty Partner Advised of 4-5 Million Ounce Silver Potential Open at Depth and Along Strike at the Coyote Project in Mexico
Soltoro Ltd. (TSX VENTURE:SOL) participates in discoveries and advancements at Coyote through its ~15% equity holding in Argentum Silver Corp. (TSX VENTURE:ASL) and its retained 3% N.S.R. royalty interest in the Coyote property.
Argentum Silver has received an independent study and evaluation on a 600 metre portion of the El Tajo vein at the Coyote Silver Project in Jalisco, Mexico. The report states a minimum target potential of between 482,000 and 876,000 tonnes at a cut-off grade between 50 and 20 grams per tonne, for a potential of between 4,000,000 and 5,000,000 ounces silver.
Theravance and Elan Enter Into a $1.0 Billion Royalty Participation Agreement
Theravance to receive $1.0 billion upfront payment upon closing; Elan to receive a 21% participation interest in potential future royalty payments associated with four respiratory programs
Theravance, Inc. (NASDAQ: THRX) and Elan Corporation, plc (NYSE: ELN) today announced that they have entered into a royalty participation agreement wherein Elan will purchase a participation interest in potential future royalty payments related to four respiratory programs partnered with GlaxoSmithKline plc (GSK): RELVAR™ ELLIPTA™/BREO™ ELLIPTA™, ANORO™ ELLIPTA™, MABA (Bifunctional Muscarinic Antagonist-Beta2 Agonist) monotherapy (GSK961081, or MABA '081), and vilanterol (VI) monotherapy. Under the terms of the agreement, Elan will make a one-time cash payment of $1.0 billion to Theravance in exchange for a 21% participation interest in the potential future royalty payments from the four programs when, as and if received by Theravance.
Dataram Announces Memory Manufacturing Partnership with Advanced Micro Devices, Inc.
Dataram Corporation [NASDAQ: DRAM]), a leading international manufacturer of computer memory and software products, announced an expanded partnership with Advanced Micro Devices, Inc. (AMD) as described in a recent press release. This partnership includes Dataram Corporation as an AMD memory-manufacturing partner to produce AMD’s new Gamer Series memory. Dataram and AMD previously announced a formal agreement for Dataram to develop an AMD-branded version of Dataram’s popular RAMDisk software. Gamer Series memory is compatible with AMD and Intel platforms, supporting both AMP and XMP memory profiles. The memory is being sold and marketed under the AMD Radeon™ Memory brand, targeting gaming enthusiasts interested in exceptional memory performance and reliability.
CardioComm Solutions Files New Patents for Automated Enabling of Over-The-Counter, Consumer, Bio-Monitoring Devices for Home Monitoring and Remote Diagnostic Interpretation
The HeartCheck PEN ECG device is the first to utilize the patent pending SMART Monitoring technologies to enable/unlock a consumer medical devices to record, display, transmit and receive bio-signals and images.
CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today confirmed it has filed for U.S. and Canadian patents for use of their proprietary technologies in the automated, software enabled and server based unlocking of over-the-counter ("OTC"), consumer based, bio-monitoring devices. Under the U.S and Canadian patents, filed on May 6, 2013 and May 8, 2013 respectively, the Company will be permitted to apply the statement "Patent Pending SMART Monitoring Technologies" in its corporate materials until the application process has been completed.
Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China
-Medicago Ready to Collaborate with Authorities to Further Study the Potential of this Vaccine to Protect Against H7N9-
Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has successfully produced a new VLP vaccine candidate for the H7N9 virus that is responsible for the current influenza outbreak in China.
Genomic Health Announces Availability of Oncotype DX® Prostate Cancer Test with Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments
Groundbreaking Results from University of California, San Francisco (UCSF) Clinical Validation Study Presented at American Urological Association (AUA) Annual Meeting First-of-its-Kind, Biopsy-Based Test Developed and Validated in Seven Studies Including More Than 1,100 Patients
Genomic Health, Inc. (GHDX) is making its Oncotype DX® prostate cancer test available to physicians and their patients today following the presentation by the University of California, San Francisco (UCSF) of a positive clinical validation study at the 2013 American Urological Association (AUA) Annual Meeting in San Diego.
Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.
Adasuve® (loxapine) inhalation powder is approved in the U.S. for the acute treatment of agitation associated with schizophrenia and bipolar disorder
Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd (TEVA), and Alexza Pharmaceuticals, Inc. (ALXA) announced today that the companies have entered into an exclusive U.S. license and supply agreement for ADASUVE (loxapine) inhalation powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. Teva will be responsible for all U.S. commercial and clinical activities for ADASUVE, including U.S. post-approval clinical studies, and has gained rights to conduct additional clinical trials of ADASUVE for potential new indications in neurological disorders. Alexza will be responsible for manufacturing and supplying ADASUVE to Teva for commercial sales and clinical trials.
Cayden Resources Provides a Corporate Update
Cayden Resources Inc. (TSX VENTURE:CYD) ("Cayden" or the "Company") is pleased to provide a corporate update to its shareholders.
Cash position and sustainability
The Company currently has a strong cash position with over two years of operating capital. The current treasury including near-term receivables is approximately $15 million and Cayden is budgeting to have in excess of $9 million in the treasury in December, after the 2013 drill programs and property payments are completed.
Cayden has the unique opportunity to obtain additional non-dilutive funding with the potential future sale of its Las Calles concession. The concession represents a strip of land, located in between the operating Los Filos and El Bermejal pits that make up Goldcorp's (TSX-G) Los Filos mine.
First Majestic Announces Completion of La Guitarra's Expansion to 500 tpd
FIRST MAJESTIC SILVER CORP. (TSX:FR)(NYSE:AG)(FRANKFURT:FMV) (the "Company" or "First Majestic") is pleased to announce that the expansion that commenced at the La Guitarra Silver Mine in November 2012 is now complete. The processing plant's capacity increased by 40% to 500 tpd from 350 tpd and commercial production is expected to reach 500 tpd during the month of May.
The construction of the new circuit was completed on budget and has been operating since April 24, 2013, without disrupting operations in the old 350 tpd circuit. This new circuit, resulting from the installation of a new ball mill and new flotation cells, is anticipated to produce approximately 1.2 million ounces of silver equivalent annually, representing over one million ounces of pure silver plus a modest amount of gold.
Synacor Expands Partnership With Verizon FiOS to Offer Seamless Content Delivery Experience and TV Everywhere Services to Pay-TV Subscribers
Through Synacor's Startpages, Verizon FiOS TV Subscribers Have Access to a Variety of Programming From HBO, Showtime, SyFy, Telemundo, NBC and More
Synacor, Inc. (SYNC), leading provider of next-gen startpages, TV Everywhere solutions and cloud-based Identity Management (IDM) services across multiple devices for cable, satellite, telecom and consumer electronics companies, today announced it has expanded its relationship with Verizon to offer the company's nearly 5 million FiOS TV subscribers access to TV shows and movies from one online destination. The My Verizon website now includes a simple search and discovery experience, easy authentication, and the ability to log in just once.
Redline Communications Lands First Wireless Digital Oil Field Project in South America
-- Deal with Major South American Oil Producer Expands Redline's Global Footprint--
Redline Communications (www.rdlcom.com Group Inc. TSX: RDL), a leading provider of broadband wireless solutions for machine-to-machine (M2M) communications, today announced that their rugged industrial wireless system was chosen to create a wireless infrastructure for a major oil producer in South America.
As in other parts of the world, the oil & gas industry in South America has turned to Enhanced Oil Recovery (EOR) techniques to increase production, safety, and to reduce the environmental impact in their mature oil fields.
Transition Therapeutics Announces Results of Clinical Study of Type 2 Diabetes Drug Candidate TT-401
Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced the results of a five-week proof of concept clinical study of TT-401 in type 2 diabetic and obese non-diabetic subjects. In the study, TT-401 a once-weekly administered peptide, demonstrated significant improvements in glycemic control and reductions in body weight.
The study enrolled diabetic patients at five dosing levels and non-diabetic obese patients at one dose level. All dosing cohorts received five doses over a five week period. Diabetic patients were on stable doses of metformin. At the end of the treatment period, TT-401-treated patients in the three highest dose groups experienced statistically significant reductions in mean fasting plasma glucose relative to placebo.
Greenbriar Capital and Alterra Power Announce Solar Partnership
Greenbriar Capital Corp. (TSXV:GRB.V) and Alterra Power Corp. (TSX:AXY.TO) are pleased to announce they have entered into a partnership, AG Solar One, which intends to develop 100 MW of solar generation capacity in Puerto Rico under a Master Renewable Power Purchase and Operating Agreement with the Puerto Rico Electric Power Authority. The partnership, which will be owned 50/50 by Greenbriar and Alterra, acquired rights to the master agreement last week.
Perpetual Energy Inc. announces exercise of option for Warwick Gas Storage, approval of IETP funding for Panny Bitumen Project and credit facility renewal
Perpetual Energy Inc. ("Perpetual" or the "Company") is pleased to announce:
1) The exercise of its option to purchase an additional 20 percent interest in Warwick Gas Storage ("WGS LP"); 2) Confirmation of funding for the Panny Bitumen Project through the Government of Alberta's Innovative Energy Technologies Program ("IETP"); and 3) Renewal of Perpetual's credit facility with a revised borrowing base of $125 million.
Warwick Gas Storage
Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
Oramed Pharmaceuticals Inc. (ORMP) (http://www.oramed.com), a developer of oral delivery systems of drugs currently administered by injection, announced today that its abstract, entitled "Oral insulin capsules toward management of Type 1 diabetes mellitus," will be presented at the Global Technology Community Diabetes Summit 2013. The poster will be presented today, April 29th, by Dr. Miriam Kidron, Oramed's Chief Scientific Officer, between 5:00pm-7:00pm EDT during the poster session and evening reception in the Ballroom Foyer of the Hyatt Regency Hotel.
SINA Forms Strategic Alliance with Alibaba to Enable Social Commerce
SINA Corporation (NASDAQ GS: SINA) ("SINA" or the "Company"), a leading online media company serving China and the global Chinese communities, announced today that it has reached an agreement on a strategic alliance between several entities affiliated with SINA, including PRC subsidiaries of Weibo Corporation ("Weibo"), and several entities affiliated with Alibaba Group ("Alibaba"), including Taobao (China) Software Co., Ltd. and Zhejiang Tmall.com Technology Co., Ltd., to jointly explore social commerce and develop innovative marketing solutions to enable merchants on Alibaba e-commerce platforms to better connect and build relationships with Weibo users.